A prospective uncontrolled study evaluating efficacy and safety of intraprostatic injection of onabotulinumtoxinA (onaBoNT-A) adult men with refractory category-III non-bacterial chronic prostatitis/chronic pelvic pain syndrome.
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Prostatitis
- Focus Therapeutic Use
- 04 Jul 2016 New trial record